gene editing
| 4 min read
FDA updates, pharma tariff agreements, gene editing deals, and more led the news this week.
| 4 min read
Cross-industry collaborations, coupled with technology innovations, could help bring CRISPR therapies to millions of patients with genetic diseases.
| 6 min read
New AI tools promise to speed up and simplify CRISPR experiments, but their real-world impact is still being tested.
| 2 min read
Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market
| 6 min read
Rather than permanently cutting DNA, this new kind of gene therapy instead aims to regulate gene expression using epigenetic mechanisms.
| 8 min read
A new approach for gene editing will get its shot in a common and chronic autoimmune disorder.
| 5 min read
Advances in microfluidics are enabling more powerful, high throughput applications in single cell and therapeutic discovery.
| 3 min read
The team at DropGenie uses digital microfluidics to perform gene editing screens on small numbers of patient cells, accelerating the discovery of new drugs.
| 5 min read
Insights from the AD/PD meeting, continued fallout from the FDA layoffs, hope for GLP-1 drugs in Alzheimer’s disease, and more led industry news this week.
| 8 min read
Virus-inspired delivery methods enable gene editing of dysregulated microbes.
